Page 1 | Search Results | Hematology, ASH Education Program

1-9 of 9

Sort by

Sort Order Select

Journal Articles

The range of haploidentical transplant protocols in sickle cell disease: all haplos are not created equally

Adetola A. Kassim, Michael R. DeBaun

Hematology Am Soc Hematol Educ Program (2023) 2023 (1): 532–541.

https://doi.org/10.1182/hematology.2023000486

Published: 2023

Journal Articles

Epidemiology and treatment of priapism in sickle cell disease

Ibrahim M. Idris, Arthur L. Burnett, Michael R. DeBaun

Hematology Am Soc Hematol Educ Program (2022) 2022 (1): 450–458.

https://doi.org/10.1182/hematology.2022000380

Published: 2022

Journal Articles

Acute pain episodes, acute chest syndrome, and pulmonary thromboembolism in pregnancy

Eugenia Vicky Asare, Michael R. DeBaun, Edeghonghon Olayemi, Theodore Boafor, Samuel A. Oppong

Hematology Am Soc Hematol Educ Program (2022) 2022 (1): 388–407.

https://doi.org/10.1182/hematology.2022000376

Published: 2022

Journal Articles

Prevention of central nervous system sequelae in sickle cell disease without evidence from randomized controlled trials: the case for a team-based learning collaborative

Michael R. DeBaun, Allison A. King

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 632–639.

https://doi.org/10.1182/asheducation-2016.1.632

Published: 2016

Journal Articles

Secondary Prevention of Overt Strokes in Sickle Cell Disease: Therapeutic Strategies and Efficacy

Michael R. DeBaun

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 427–433.

https://doi.org/10.1182/asheducation-2011.1.427

Published: 2011

Journal Articles

What Is the Evidence for Using Hydroxyurea for Secondary Stroke Prevention?

Jeffrey D. Lebensburger, Michael R. DeBaun, Alexis A. Thompson

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 440–442.

https://doi.org/10.1182/asheducation-2011.1.440

Published: 2011

Journal Articles

Asthma and sickle cell disease: two distinct diseases or part of the same process?

Joshua J. Field, Michael R. DeBaun

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 45–53.

https://doi.org/10.1182/asheducation-2009.1.45

Published: 2009

Journal Articles

Limitations of Clinical Trials in Sickle Cell Disease: A Case Study of the Multi-center Study of Hydroxyurea (MSH) Trial and the Stroke Prevention (STOP) Trial

Michael R. DeBaun, Joshua J. Field

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 482–488.

https://doi.org/10.1182/asheducation-2007.1.482

Published: 2007

Journal Articles

Sickle Cell Disease

George R. Buchanan, Michael R. DeBaun, Charles T. Quinn, Martin H. Steinberg

Hematology Am Soc Hematol Educ Program (2004) 2004 (1): 35–47.

https://doi.org/10.1182/asheducation-2004.1.35

Published: 2004

NARROW

The range of haploidentical transplant protocols in sickle cell disease: all haplos are not created equally

Epidemiology and treatment of priapism in sickle cell disease

Acute pain episodes, acute chest syndrome, and pulmonary thromboembolism in pregnancy

Prevention of central nervous system sequelae in sickle cell disease without evidence from randomized controlled trials: the case for a team-based learning collaborative

Secondary Prevention of Overt Strokes in Sickle Cell Disease: Therapeutic Strategies and Efficacy

What Is the Evidence for Using Hydroxyurea for Secondary Stroke Prevention?

Asthma and sickle cell disease: two distinct diseases or part of the same process?

Limitations of Clinical Trials in Sickle Cell Disease: A Case Study of the Multi-center Study of Hydroxyurea (MSH) Trial and the Stroke Prevention (STOP) Trial

Sickle Cell Disease

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only